Virginia Tech awarded $1 million grant to study Duchenne Muscular Dystrophy
dc.contributor.author | Johnson, Mary Ann | en |
dc.coverage.spatial | Blacksburg, Va. | en |
dc.date.accessioned | 2013-05-06T19:31:30Z | en |
dc.date.available | 2013-05-06T19:31:30Z | en |
dc.date.issued | 2004-11-10 | en |
dc.description.abstract | A $1 million grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health will fund research at Virginia Tech to identify the cell-level mechanisms that start Duchenne Muscular Dystrophy, a progressive and fatal muscle weakness disease that occurs in approximately one in 3,500 males. | en |
dc.format.mimetype | text/html | en |
dc.identifier.uri | http://hdl.handle.net/10919/21286 | en |
dc.publisher | Virginia Tech. University Relations | en |
dc.rights | In Copyright | en |
dc.rights.holder | Virginia Tech. University Relations | en |
dc.rights.uri | http://rightsstatements.org/vocab/InC/1.0/ | en |
dc.title | Virginia Tech awarded $1 million grant to study Duchenne Muscular Dystrophy | en |
dc.type | Press release | en |
dc.type.dcmitype | Text | en |
Files
Original bundle
1 - 1 of 1